Monashee Investment Management LLC Humanigen, Inc Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$13.54 - $22.74 $2.03 Million - $3.41 Million	-150,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$12.91 - $23.83 $1.94 Million - $3.57 Million	150,000 New	150,000 $2.87 Million
Q4 2020 Feb 11, 2021	SELL	$7.97 - $21.66 $1.59 Million - $4.33 Million	-200,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$8.0 - $28.5 $1.6 Million - $5.7 Million	200,000 New	200,000 $2.13 Million

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.